Published in Lab Invest on September 01, 1976
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest (1980) 2.07
Association and dissociation of aggregated IgG from rat peritoneal macrophages. J Exp Med (1977) 1.61
Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med (1982) 1.54
The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology (1982) 1.54
The influence of phagocyte function on glomerular localization of aggregated IgM in rats. Clin Exp Immunol (1978) 1.38
Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J Exp Med (1988) 1.34
Clearance and tissue uptake of immune complexes in complement-depleted and control mice. Immunology (1981) 1.20
Clearance kinetics of soluble pre-formed immune complexes containing IgM antibodies in normal and decomplemented rabbits. Immunology (1981) 1.17
Influence of antigen on immune complex behavior in mice. J Clin Invest (1981) 1.14
Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect Immun (1997) 1.12
Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system. Clin Exp Immunol (1982) 0.98
FcγRIIb on liver sinusoidal endothelium clears small immune complexes. J Immunol (2012) 0.98
Effect of preformed immune complexes on the clearance and tissue localization of single-stranded DNA in mice. Clin Exp Immunol (1980) 0.98
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest (1989) 0.97
Modification of glomerular immune complex deposition in mice by activation of the reticuloendothelial system. J Clin Invest (1981) 0.96
Bovine serum albumin nephritis in rats. V. Kinetic studies of antigen localization in various organs and the phagocytic role of polymorphonuclear leukocytes. Am J Pathol (1985) 0.91
Hepatic uptake of small-latticed immune complexes does not alter mononuclear phagocyte system function. Immunology (1983) 0.90
Clearance and organ localization of particles and soluble complexes in mice with circulating complexes. Immunology (1984) 0.90
Repeated exposure to bacterial lipopolysaccharide interferes with disposal of pathogenic immune complexes in mice. Clin Exp Immunol (1990) 0.85
Liver cell membrane antibody detected by protein A and isolated rabbit liver plasma membrane in sera of patients with chronic liver diseases. Clin Exp Immunol (1983) 0.84
Uptake of aggregated immunoglobulin by the mouse kidney. II. Effect of hydrocortisone. Br J Exp Pathol (1980) 0.81
The effect of charge on the renal distribution of ferritin. Am J Pathol (1983) 0.79
Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice. Clin Exp Immunol (1990) 0.78
Mesangial function in ureteral obstruction in the rat. Blockade of the efferent limb. J Clin Invest (1979) 0.76
Regulation of immune-aggregate-stimulated hepatic glycogenolysis and vasoconstriction by vicinal dithiols. Biochem J (1988) 0.75
Receptor mediated endocytosis by mesangial cells modulates transmigration of macrophages. Inflammation (2000) 0.75
Individual Antigenic Specificity of Isolated Antibodies. Science (1963) 7.27
Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol (1974) 3.65
Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med (1971) 3.51
The macrophage receptor for IgG: number and affinity of binding sites. J Immunol (1973) 2.91
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
In vitro adherence of soluble immune complexes to macrophages. J Exp Med (1972) 2.26
Immunoglobulins in temporal arteries. An immunofluorescent study. Ann Intern Med (1974) 2.02
The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 2.01
Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits. J Immunol (1971) 1.77
The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc Natl Acad Sci U S A (1974) 1.76
Specificity of recombination of H and L chains from human gamma-G-myeloma proteins. J Exp Med (1965) 1.69
Molecular composition and sedimentation characteristics of soluble antigen-antibody complexes. Biochemistry (1972) 1.64
Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes. J Immunol (1975) 1.62
Antigen retention in joint tissues in antigen-induced synovitis. Clin Exp Immunol (1974) 1.61
Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J Immunol (1989) 1.59
Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med (1982) 1.54
The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors. Arthritis Rheum (1975) 1.54
Antibody-agarose immunoadsorbents: complete removal of classes of immunoglobulins from serum. J Immunol (1971) 1.54
The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology (1982) 1.54
Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup. J Immunol (1991) 1.49
Kinetics and mechanisms for removal of circulating single-stranded DNA in mice. J Exp Med (1978) 1.46
Removal of glomerular deposits of immune complexes in mice by administration of excess antigen. Lab Invest (1980) 1.42
The distribution of antigenic determinants in rat skin collagen. J Exp Med (1971) 1.35
Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA. J Immunol (1983) 1.34
Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol (1998) 1.32
Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice. J Exp Med (1984) 1.31
Pathophysiology of circulating immune complexes. Arthritis Rheum (1982) 1.28
Binding of albumin to gamma-A-myeloma proteins and Waldenström macroglobulins by disulfide bonds. J Immunol (1967) 1.28
The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med (1993) 1.26
Clearance of circulating DNA-anti-DNA immune complexes in mice. J Exp Med (1982) 1.23
Clearance and tissue uptake of immune complexes in complement-depleted and control mice. Immunology (1981) 1.20
The molecular basis of self-association of IgG-Rheumatoid factors. J Immunol (1975) 1.19
IgG rheumatoid factors and staphylococcal protein A bind to a common molecular site on IgG. J Exp Med (1985) 1.18
Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol (1984) 1.15
Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol (1996) 1.15
Fate of preformed immune complexes in rabbits and rhesus monkeys. J Exp Med (1971) 1.14
Determination of soluble immune complex molar composition and antibody association constants by ammonium sulfate precipitation. J Immunol (1974) 1.14
7S M-globulin in rheumatoid arthritis. Evaluation of its clinical significance. Arthritis Rheum (1971) 1.13
Studies on the antigenic determinants in the self-association of IgG rheumatoid factor. J Exp Med (1981) 1.12
Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med (1983) 1.11
Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med (1983) 1.09
Nonimmunospecific protein-protein interactions of IgG: studies of the binding of IgG to IgG immunoadsorbents. J Immunol (1978) 1.08
Physicochemical and functional relationships of immune complexes. J Invest Dermatol (1980) 1.07
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest (1988) 1.07
Intermediate complexes formed by self-association of IgG-rheumatoid factors. Ann N Y Acad Sci (1975) 1.05
Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum (1989) 1.05
Self-associating IgG rheumatoid factors in MRL/l autoimmune mice. Arthritis Rheum (1984) 1.04
The immune response in the hamster. IV. Studies on IgA. J Immunol (1971) 1.04
Glomerular localization of preformed immune complexes prepared with anionic antibodies or with cationic antigens. Lab Invest (1984) 1.03
IgG rheumatoid factors and self-association of these antibodies. Clin Rheum Dis (1985) 1.01
Interaction between herpes simplex type 1-induced Fc receptor and human and rabbit immunoglobulin G (IgG) domains. Immunology (1986) 1.00
Covalent binding of molecules to CNBr-activated agarose: parameters relevant to the activation and coupling reactions. Biochim Biophys Acta (1974) 1.00
Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab). Arthritis Rheum (2001) 1.00
Rheumatoid factors from patients with rheumatoid arthritis possess private repertoires of idiotypes. J Immunol (1987) 1.00
Evaluation of immunological specificity of flurescein-conjugated antisera with agarose-antigen sections. Infect Immun (1975) 1.00
Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system. Clin Exp Immunol (1982) 0.98
Rheumatoid factors in rheumatoid arthritis. Bull Rheum Dis (1973) 0.98
Effect of preformed immune complexes on the clearance and tissue localization of single-stranded DNA in mice. Clin Exp Immunol (1980) 0.98
Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells. Rheumatol Int (1983) 0.97
Mechanisms of tissue deposition of immune complexes. J Rheumatol Suppl (1987) 0.96
Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin Immunol Immunopathol (1991) 0.96
Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) (1987) 0.96
Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C gamma 2-C gamma 3 interface region contains the major determinants. J Immunol (1988) 0.94
Covalently cross-linked immune complexes prepared with multivalent cross-linking antigens. J Immunol (1981) 0.93
Removal of glomerular immune complex deposits by excess antigen in chronic mouse model of immune complex disease. Lab Invest (1983) 0.93
Immunologically induced acute synovitis in rabbits. Studies of immune complexes in synovial fluid. Arthritis Rheum (1973) 0.92
Hepatic uptake of small-latticed immune complexes does not alter mononuclear phagocyte system function. Immunology (1983) 0.90
Blood viscosity in Waldenström's macroglobulinemia. Blood (1974) 0.90
Preparation and characterization of 4-azido-2-nitrophenyl human serum albumin as an antigen for covalent cross-linking of immune complexes. J Immunol (1981) 0.89
Human rheumatoid factors bear the internal image of the Fc binding region of staphylococcal protein A. J Exp Med (1987) 0.89
Mechanisms of immune deposit formation in renal glomeruli. Springer Semin Immunopathol (1986) 0.89
Only the initial binding of cationic immune complexes to glomerular anionic sites is mediated by charge-charge interactions. J Immunol (1986) 0.87
Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol (1985) 0.87
A method for isolation of mouse glomeruli for quantitation of immune deposits. Kidney Int (1988) 0.87
Immune complexes with cationic antibodies deposit in glomeruli more effectively than cationic antibodies alone. J Immunol (1987) 0.86
Identification of the site on IgG Fc for interaction with streptococci of groups A, C and G. Immunology (1987) 0.86
Interaction between streptococcal IgG Fc receptors and human and rabbit IgG domains. Immunology (1986) 0.85
Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein. Am J Med (1973) 0.85
A small proportion of cationic antibodies in immune complexes is sufficient to mediate their deposition in glomeruli. J Immunol (1990) 0.85
Selective losses of large immune complexes during density gradient ultracentrifugation and an approach for prevention of these losses. J Immunol Methods (1985) 0.84
Variability in the specific interactions of H and L chains of gamma-G-globulins. Biochemistry (1967) 0.84
Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells. Am J Pathol (1988) 0.84
The location of binding sites on C1q for DNA. J Immunol (1990) 0.83
Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis. Rheumatol Int (1990) 0.83
Human complement activation by self-associated IgG rheumatoid factors. Arthritis Rheum (1982) 0.83
Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum (1977) 0.82
C1q-binding immunoglobulin G in MRL/l mice consists of immune complexes containing antibodies to DNA. Clin Immunol Immunopathol (1995) 0.81
Binding of double-stranded DNA to glomeruli of rats in vivo. Arthritis Rheum (1989) 0.81
Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice. Immunology (1987) 0.81
Competition between antigen and anti-idiotypes for rheumatoid factors. J Immunol (1985) 0.80
In situ formation of immune complexes in the choroid plexus of rats by sequential injection of a cationized antigen and unaltered antibodies. J Neuropathol Exp Neurol (1984) 0.80
IgG subclasses of antibodies to the collagen-like region of C1q in patients with systemic lupus erythematosus. Arthritis Rheum (1989) 0.80
Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein. N Engl J Med (1997) 0.80